CAPITALHILL ADVISORY for MERCK SHARP & DOHME
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Australian Government policy on intellectual property and its impact on the Australian healthcare system.
Foreign entity interest: Australian Government Impact of policy on the company's local business environment
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICHOLAS CAMPBELL | — |
Trade (domestic/foreign) TRD
Australian Government policy on intellectual property and its impact on the Australian healthcare system.
Foreign entity interest: Australian Government Impact of policy on the company's local business environment
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICHOLAS CAMPBELL | — |
Pharmacy PHA
Australian Government policy on intellectual property and its impact on the Australian healthcare system.
Foreign entity interest: Australian Government Impact of policy on the company's local business environment
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICHOLAS CAMPBELL | — |
Health Issues HCR
Australian Government policy on intellectual property and its impact on the Australian healthcare system.
Foreign entity interest: Australian Government Impact of policy on the company's local business environment
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICHOLAS CAMPBELL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.